Twin Tree Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23
| Closed | -$6.87K | – | 1943 |
|
|
2025
Q1 | $7.09K | Buy |
+23
| New | +$7.88K | ﹤0.01% | 1499 |
|
|
2024
Q4 | – | Sell |
-29,318
| Closed | -$10.5M | – | 1923 |
|
|
2024
Q3 | $10.5M | Sell |
29,318
-5,406
| -16% | -$1.83M | 0.02% | 639 |
|
|
2024
Q2 | $11.1M | Buy |
+34,724
| New | +$9.19M | 0.03% | 555 |
|
|
2023
Q3 | – | Sell |
-1,842
| Closed | -$407K | – | 1569 |
|
|
2023
Q2 | $407K | Buy |
1,842
+1,073
| +140% | +$238K | ﹤0.01% | 1075 |
|
|
2023
Q1 | $172K | Sell |
769
-20,739
| -96% | -$5.11M | ﹤0.01% | 1133 |
|
|
2022
Q4 | $5.98M | Buy |
21,508
+17,051
| +383% | +$4.3M | 0.01% | 699 |
|
|
2022
Q3 | $933K | Sell |
4,457
-12,438
| -74% | -$2.78M | ﹤0.01% | 1058 |
|
|
2022
Q2 | $3.98M | Sell |
16,895
-35,026
| -67% | -$7.12M | 0.01% | 911 |
|
|
2022
Q1 | $9.31M | Buy |
51,921
+36,928
| +246% | +$7.04M | 0.01% | 719 |
|
|
2021
Q4 | $3.24M | Buy |
14,993
+9,417
| +169% | +$1.85M | 0.01% | 971 |
|
|
2021
Q3 | $1.03M | Sell |
5,576
-24,660
| -82% | -$4.86M | ﹤0.01% | 1182 |
|
|
2021
Q2 | $5.42M | Sell |
30,236
-37,737
| -56% | -$7.19M | 0.01% | 675 |
|
|
2021
Q1 | $11.4M | Buy |
67,973
+38,598
| +131% | +$6.44M | 0.04% | 421 |
|
|
2020
Q4 | $4.46M | Buy |
29,375
+29,374
| +2,937,400% | +$3.85M | 0.02% | 658 |
|
|
2020
Q3 | $0 | Sell |
1
-3,043
| -100% | -$334K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $368K | Buy |
+3,044
| New | +$343K | ﹤0.01% | 1196 |
|
|
2019
Q2 | – | Sell |
-5,119
| Closed | -$601K | – | 1564 |
|
|
2019
Q1 | $601K | Buy |
+5,119
| New | +$596K | ﹤0.01% | 927 |
|
|
2018
Q1 | – | Sell |
-5,904
| Closed | -$873K | – | 1315 |
|
|
2017
Q4 | $873K | Buy |
+5,904
| New | +$751K | 0.01% | 737 |
|
|
2017
Q2 | – | Sell |
-397
| Closed | -$49.5K | – | 1170 |
|
|
2017
Q1 | $54K | Sell |
397
-12,501
| -97% | -$1.89M | ﹤0.01% | 900 |
|
|
2016
Q4 | $1.85M | Buy |
12,898
+9,828
| +320% | +$1.25M | 0.02% | 640 |
|
|
2016
Q3 | $363K | Buy |
+3,070
| New | +$369K | ﹤0.01% | 878 |
|
|
2015
Q3 | – | Sell |
-1,087
| Closed | -$174K | – | 1521 |
|
|
2015
Q2 | $189K | Sell |
1,087
-3,018
| -74% | -$543K | ﹤0.01% | 1078 |
|
|
2015
Q1 | $708K | Buy |
4,105
+3,021
| +279% | +$461K | 0.02% | 698 |
|
|
2014
Q4 | $140K | Buy |
+1,084
| New | +$140K | ﹤0.01% | 948 |
|
Other funds holding UTHR
ACA
Twin Tree Management's UTHR Position: Q2 2025 in Review
Twin Tree Management sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 23 shares — an estimated $6.87K sold.
Twin Tree Management first reported a position in UTHR in Q4 2014 and held it in 24 quarters. The position peaked at $11.4M in Q1 2021. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.
- Twin Tree Management reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
- Twin Tree Management sold 23 United Therapeutics shares in Q2 2025, an estimated $6.87K.
- Twin Tree Management first reported a position in United Therapeutics in Q4 2014 and held it in 24 quarters.
- Twin Tree Management's United Therapeutics position peaked at $11.4M in Q1 2021.
- 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.
Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.